Platelet antistaphylococcal responses occur through P2X1 and P2Y12 receptor-induced activation and kinocidin release

Darin A Trier1, Kimberly D Gank, Deborah Kupferwasser

  • 1Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA 90509, USA.

Infection and Immunity
|October 1, 2008
PubMed

Insights

Platelets (PLTs) kill Staphylococcus aureus by releasing microbicidal proteins (PMPs) and kinocidins (PKs). P2X(1) and P2Y(12) receptor activation amplifies this antimicrobial response, crucial for host defense.

Area of Science:

  • Immunology
  • Microbiology
  • Hematology

Background:

  • Platelets (PLTs) play a role in antimicrobial host defense.
  • PLTs release microbicidal proteins (PMPs) and kinocidins (PKs) with antibacterial properties.

Purpose of the Study:

  • To investigate the receptors mediating the staphylocidal efficacy of PLTs.
  • To examine the release of PMPs and PKs against Staphylococcus aureus strains in vitro.

Main Methods:

  • Isolated PLTs were incubated with isogenic PMP-susceptible and -resistant Staphylococcus aureus strains.
  • PLT inhibitors targeting P2X and P2Y receptors, and adhesion receptors were used.
  • Reversed-phase high-performance liquid chromatography analyzed releasates.

Main Results:

  • A PLT-to-S. aureus ratio of ≥10:1 significantly reduced bacterial viability.
  • P2X(1) and P2Y(12) receptor antagonists (e.g., pyridoxal 5'-phosphonucleotide derivative, cangrelor) mitigated the staphylocidal response and reduced PMP/PK release.
  • Inhibition of thromboxane A(2), COX, PLC pathways, or adhesion receptors did not impede the anti-S. aureus response.

Conclusions:

  • Platelet antimicrobial activity against S. aureus is multifactorial.
  • Key mechanisms include sufficient PLT activation, degranulation of PMPs/PKs, P2X(1)/P2Y(12) receptor activation on adjacent PLTs, and amplification of PMP/PK release.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Inflammation01:38

Inflammation

Overview